Files and links (1)
Honeybee products for the treatment and recovery from viral respiratory infections including SARS-COV-2: A rapid systematic review
Published (Version of record)CC BY-NC-ND V4.0, Open
Journal article
Honeybee products for the treatment and recovery from viral respiratory infections including SARS-COV-2: A rapid systematic review
Integrative Medicine Research, Vol.10, 100779
01/10/2021
PMID: 34611512
Metrics
38 Record Views
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Abstract
Background: This rapid review systematically evaluated the effects of honeybee products compared to controls for the prevention, duration, severity, and recovery of acute viral respiratory tract infections (RTIs), including SARS-CoV-2, in adults and children.
Methods: Cochrane rapid review methods were applied. Four English databases plus preprint servers and trial registries were searched for randomized controlled trials (RCTs). The evidence was appraised and synthesized using RoB 2.0 and GRADE.
Results: 27 results were derived from 9 RCTs that included 674 adults and 781 children. In hospitalized adults with SARS-CoV-2, propolis plus usual-care compared to usual-care alone reduced the risk of shock, respiratory failure and kidney injury and duration of hospital admission. Honey was less effective than Guaifenesin for reducing cough severity at 60-minutes in adults with non-specific acute viral RTIs. Compared to coffee, honey plus coffee, and honey alone reduced the severity of post-infectious cough in adults. Honey reduced the duration of cough in children compared to placebo and salbutamol; and the global impact of nocturnal cough after one night compared to usual-care alone and pharmaceutical cough medicines.
Conclusion: More studies are needed to robustly assess honeybee’s role in SARS-CoV-2 and non-specific
viral respiratory infections.
Details
- Title
- Honeybee products for the treatment and recovery from viral respiratory infections including SARS-COV-2: A rapid systematic review
- Creators
- Susan Arentz - NICM Health Research Institute, Western Sydney University, Sydney, NSW, AustraliaJennifer Hunter - NICM Health Research Institute, Western Sydney University, Sydney, NSW, AustraliaBaljit Khamba - Bastyr University, San Diego, CA, USAMichelle Mravunac - Torrens University, Sydney, NSW, AustraliaZemirah Lee - Bastyr University, San Diego, CA, USAKristen Alexander - Bastyr University, San Diego, CA, USARomy Lauche - National Centre for Naturopathic Medicine, Faculty of Health, Southern Cross University, Lismore, NSW AustraliaJoshua Goldenberg - Helfgott Research Institute, National University of Natural Medicine, Portland, OR & Seattle, WA, USAStephen P Myers - NICM Health Research Institute, Western Sydney University, Sydney, NSW, Australia
- Publication Details
- Integrative Medicine Research, Vol.10, 100779
- Publisher
- Elsevier B.V
- Identifiers
- 991012968488102368
- Copyright
- This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
- Academic Unit
- Office of the Vice Chancellor; National Centre for Naturopathic Medicine; Office of Senior Deputy Vice Chancellor, Research
- Language
- English
- Resource Type
- Journal article